[Not Available].
作者信息
López Rodríguez Cristina A, Pons Marc Boigues, Sánchez Bibiana Quirant, Serra Aina Teniente, Martí Joan Climent, Martínez Cáceres Eva Ma
机构信息
Immunology Division, Laboratori Clínic Metropolitana Nord, Germans Trias i Pujol University Hospital, Barcelona, Spain.
出版信息
Adv Lab Med. 2020 Nov 2;1(4):20200083. doi: 10.1515/almed-2020-0083. eCollection 2020 Dec.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]
Adv Lab Med. 2020 Nov 2;1(4):20200083. doi: 10.1515/almed-2020-0083. eCollection 2020 Dec.
本文引用的文献
1
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19.基于中性粒细胞与淋巴细胞比值和IgG水平的免疫表型分析可预测COVID-19患者的疾病严重程度和预后。
Front Mol Biosci. 2020 Jul 3;7:157. doi: 10.3389/fmolb.2020.00157. eCollection 2020.
2
Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.新型冠状病毒（SARS-CoV-2）感染的血清学检测在 COVID-19 疫情期间的诊断评估。
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2271-2277. doi: 10.1007/s10096-020-03978-6. Epub 2020 Jul 17.
3
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.瑞德西韦治疗 COVID-19：系统的获益-风险评估。
Drug Saf. 2020 Jul;43(7):645-656. doi: 10.1007/s40264-020-00952-1.
4
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.通过单细胞测序对新冠康复期患者的免疫细胞进行分析
Cell Discov. 2020 May 4;6:31. doi: 10.1038/s41421-020-0168-9. eCollection 2020.
5
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.新冠病毒疾病在自然状态和免疫抑制状态下：一项临床治疗分期建议。
J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.
6
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎（COVID-19）患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
7
The race for coronavirus vaccines: a graphical guide.新冠疫苗竞赛：图解指南
Nature. 2020 Apr;580(7805):576-577. doi: 10.1038/d41586-020-01221-y.
8
The potential danger of suboptimal antibody responses in COVID-19.新冠肺炎中抗体反应欠佳的潜在危险。
Nat Rev Immunol. 2020 Jun;20(6):339-341. doi: 10.1038/s41577-020-0321-6.
9
Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.新型冠状病毒肺炎患者的抗体检测及动态特征。
Clin Infect Dis. 2020 Nov 5;71(8):1930-1934. doi: 10.1093/cid/ciaa461.
10
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19.患者康复前伴随免疫反应的广度：非重症COVID-19病例报告
Nat Med. 2020 Apr;26(4):453-455. doi: 10.1038/s41591-020-0819-2.
Zotero 插件